Holen Sie sich die Stockscreener-App
175.75
1.20%
2.09
Vorhandelsmarkt:
176.75
1.00
+0.57%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt THC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$173.66
Offen:
$172.25
24-Stunden-Volumen:
946.75K
Relative Volume:
0.59
Marktkapitalisierung:
$14.54B
Einnahmen:
$20.52B
Nettoeinkommen (Verlust:
$1.46B
KGV:
11.62
EPS:
15.12
Netto-Cashflow:
$1.41B
1W Leistung:
+2.48%
1M Leistung:
+8.88%
6M Leistung:
+37.34%
1J Leistung:
+31.42%
1-Tages-Spanne:
$171.53
$175.96
1-Wochen-Bereich:
$169.03
$175.96
52-Wochen-Spanne:
$109.82
$178.76
Tenet Healthcare Corp Stock (THC) Company Profile
Firmenname
Tenet Healthcare Corp
Sektor
Branche
Telefon
469-893-2200
Adresse
14201 DALLAS PARKWAY, DALLAS, TX
Vergleichen Sie THC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THC
Tenet Healthcare Corp
|
175.75 | 14.54B | 20.52B | 1.46B | 1.41B | 15.12 |
|
HCA
Hca Healthcare Inc
|
376.07 | 87.79B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
27.04 | 16.81B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
118.43 | 12.02B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
182.52 | 11.13B | 16.08B | 1.20B | 1.06B | 17.82 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-02-26 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-16 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-22 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Eingeleitet | JP Morgan | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-03-29 | Eingeleitet | Wells Fargo | Overweight |
| 2022-02-10 | Hochstufung | UBS | Neutral → Buy |
| 2022-02-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-02-09 | Hochstufung | Truist | Hold → Buy |
| 2022-01-20 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Neutral |
| 2021-08-12 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-23 | Fortgesetzt | Citigroup | Buy |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-03 | Fortgesetzt | Goldman | Buy |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-15 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-11 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-26 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-12-09 | Hochstufung | UBS | Neutral → Buy |
| 2019-11-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-08-14 | Fortgesetzt | Goldman | Neutral |
| 2019-02-26 | Bestätigt | BofA/Merrill | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-12-17 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-06-29 | Herabstufung | Jefferies | Buy → Hold |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-30 | Fortgesetzt | Wells Fargo | Market Perform |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-19 | Bestätigt | Mizuho | Neutral |
| 2017-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Tenet Healthcare Corp Aktie (THC) Neueste Nachrichten
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term - Yahoo Finance
Ambulatory Surgical Center Market Is Booming So Rapidly - openPR.com
Tenet Sues Blue Cross Over $21M In Unpaid Medical Claims - Law360
Is Tenet (THC) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
2 Reasons to Like THC and 1 to Stay Skeptical - Yahoo Finance
RBC Sees Limited Exposure to Medicaid Risks for Tenet (THC), Reiterated $189 Target - Insider Monkey
Tenet Healthcare stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com
Tenet Healthcare upgraded to BB- by S&P on improved performance - Investing.com India
Tenet Healthcare Corp (THC) on the Spot over Medicare Fraud Allegations - MSN
Tenet Healthcare (THC) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
12 Best Healthcare Stocks to Buy Now - Insider Monkey
Morgan Stanley Raises Tenet Healthcare (THC) PT to $210, Keeps Overweight Rating - Insider Monkey
2018-up-and-comers-brittany-lavis - Modern Healthcare
Here's Why Tenet Healthcare (THC) is a Strong Value Stock - Yahoo Finance
Trevor Fetter - Modern Healthcare
Ronald Rittenmeyer - Modern Healthcare
2012-up-and-comers-monica-vargas-mahar - Modern Healthcare
Kent Wallace - Modern Healthcare
8 Best Inexpensive Stocks to Buy Right Now - Insider Monkey
Tenet Healthcare (THC) Shares Drop Amid Short Report and Sector Concerns - GuruFocus
Tenet Healthcare (THC) Faces Scrutiny from Fuzzy Panda Research | THC Stock News - GuruFocus
Tenet Healthcare Corp (THC) Shares Up 3.03% on Jun 11 - GuruFocus
Tenet (THC) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Tenet Healthcare (THC) Faces Scrutiny from Fuzzy Panda Research - GuruFocus
Tenet Healthcare flat after Fuzzy Panda issues short report - Seeking Alpha
Tenet Healthcare stock falls after Fuzzy Panda short report alleges Medicare fraud - Investing.com Canada
Fuzzy Panda Says Short Tenet Healthcare - MarketScreener
Tenet Healthcare (THC) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Tenet Healthcare Gets Narrowed Suit Over Online Tracking Pixels - Bloomberg Law News
Providence starts work on $21M medical office building at future hospital site on Eastlake - El Paso Times
Tenet Healthcare (THC) Receives Price Target Boost from Morgan S - GuruFocus
Tenet Healthcare (THC) Receives Price Target Boost from Morgan Stanley | THC Stock News - GuruFocus
What Makes Tenet Healthcare (THC) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Insider Sell: Richard Fisher Sells Shares of Tenet Healthcare Co - GuruFocus
Should Value Investors Buy Tenet Healthcare (THC) Stock? - Yahoo Finance
Tenet appoints first COO - healthcaredive.com
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Tenet Healthcare (THC) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Finance
Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know - Yahoo Finance
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Tenet Healthcare Corp. (THC) - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tenet Healthcare Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 6, 2016THC - ACCESS Newswire
Tenet Healthcare (THC) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Tenet Healthcare Corporation (THC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Here's How Much You'd Have If You Invested $1000 in Tenet Healthcare a Decade Ago - Yahoo Finance
Healthcare Giant The Joint Taps C-Suite Veteran From Tenet, Kimberly-Clark to Drive Growth Strategy - Stock Titan
12 Analysts Assess Tenet Healthcare: What You Need To Know - Benzinga
Barclays Raises Price Target for Tenet Healthcare (THC) to $215 - GuruFocus
Barclays Analyst Raises Target for Tenet Healthcare (THC) to $215 | THC Stock News - GuruFocus
Tenet Healthcare (THC): Company Profile, Stock Price, News, Rankings - Fortune
Insider Sell: James Bierman Sells 4,613 Shares of Tenet Healthca - GuruFocus
Tenet healthcare director James Bierman sells $784,210 in stock By Investing.com - Investing.com South Africa
Finanzdaten der Tenet Healthcare Corp-Aktie (THC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tenet Healthcare Corp-Aktie (THC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Arbour Paola M | EVP, Chief Information Officer |
Jun 05 '25 |
Sale |
173.00 |
7,738 |
1,338,674 |
20,110 |
1.49%
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):